This R06-6D3 recombinant monoclonal antibody has the ability to specifically bind to human PDGFRA. It cross-reacts with mouse, rat. This PDGFR alpha antibody was verified by western blot analysis of PDGF Receptor alpha in C6, 3T3 lysates.
Figure 1 Anti-PDGFRA Antibody (VS3-FY1820) in WB.
The PDGF Receptor alpha expression in C6, 3T3 lysates were detected using the anti-PDGFR alpha by western blot assay.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-192 | Anti-Human PDGF-R alpha Recombinant Antibody (Olaratumab) | IF, IP, Neut, FuncS, ELISA, FC, ICC | IgG1 - kappa |
TAB-878 | Anti-Human CD140a Recombinant Antibody (Tovetumab) | ELISA, FC, IP, FuncS, IF, Neut, WB | IgG2 - kappa |
TAB-1063CL | Human Anti-PDGFRA Recombinant Antibody (TAB-1063CL) | FuncS | Human antibody |
TAB-1063CL-S(P) | Human Anti-PDGFRA Recombinant Antibody; scFv Fragment (TAB-1063CL-S(P)) | ELISA | Human scFv |
TAB-1063CL-F(E) | Human Anti-PDGFRA Recombinant Antibody; Fab Fragment (TAB-1063CL-F(E)) | ELISA | Human Fab |
There are currently no Customer reviews or questions for VS3-FY1820. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.